Clinical Trial Update: Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing bevacizumab plus cisplatin against cisplatin alone for malignant serous effusions is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Ascites
• Malignant Pleural Effusion

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Qingdao Central Hospital | Conditions: Overall Response Rate | Phase 2 | Status: RECRUITING